Article Text

Download PDFPDF
CASE REPORT
Primary malignant melanoma of the urethra in a patient with rheumatoid arthritis treated with methotrexate
  1. Margrethe Foss Hansen1,
  2. Ivan Abel1 and
  3. Erik Clasen-Linde2
  1. 1 Department of Obstetrics and Gynaecology, Nordssjællands Hospital, Hillerød, Denmark
  2. 2 Department of Pathology, Rigshospitalet, Kobenhavn, Denmark
  1. Correspondence to Ms Margrethe Foss Hansen, margrethe.foss.hansen.02{at}regionh.dk

Abstract

We report a case of a 79-year-old woman with urinary incontinence who presented at a urogynaecology appointment. Her medical history included rheumatoid arthritis (RA) treated with methotrexate (MXT) for 22 years. A polypoidal lesion was protruding from the meatus urethrae. The histoimmunocytology confirmed a primary superficial spreading malignant melanoma. The tumour was extensively excised, but 8 months later, due to a lymphatic nodal swelling, a positron emission tomography/CT was performed showing a process suspicious of malignant melanoma and multiple distant metastasis. The subsequent treatment was palliative and 1 year later, the patient died. The aetiology of malignant melanomas in the urethra is poorly understood. There is consistent evidence that RA is associated with a number of cancers, but it remains controversial whether this risk is increased with MXT. This case emphasises the importance of gynaecological examination even in patients with only weak symptoms from the pelvic region, especially in patients undergoing immunosuppressive treatment.

  • drugs: obstetrics and gynaecology
  • incontinence
  • dermatological
  • pathology
  • urological cancer
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors MFH interpreted the data and wrote the manuscript. IA acquired the data and edited the manuscript. EC-L acquired the data and edited the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Next-of-kin consent was obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.